New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
08:23 EDTMDXGMiMedx still a top pick, says Canaccord
Canaccord reiterated its Buy rating and top pick designation for MiMedx following the company's raised guidance. The firm believes fundamentals are in place to drive execution in wound care for the foreseeable future as the company's increase in sales force remains ahead of plan and reimbursement changes support growth and increased expectations. Canaccord has a $12 price target on the stock.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
09:17 EDTMDXGMiMedx Q4 results likely to beat consensus, says Needham
Subscribe for More Information
December 15, 2014
08:50 EDTMDXGMiMedx sees Q1 revenue $40M-$41M, consensus $39.26M
Sees Q1 operating profit margin to be in excess of 10%. Sees FY15 operating profit margin to be in excess of 15%.
08:48 EDTMDXGMiMedx raises FY15 revenue view to $190M from $175M, consensus $181.1M
Subscribe for More Information
December 11, 2014
09:35 EDTMDXGMiMedx management to meet with Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use